DNA X, Inc. (SONM) Fair Value 2026

SONM · Telephone & Telegraph Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.1 /10

32 fundamental signals · 9 models active

Value Trap Risk

LOW (39/100)

Quick Summary — As of 2026-07-13, DNA X, Inc. (SONM) trades at $4.34, approximately 375% above CirclFi’s Bayesian DCF fair value of $0.91. QOC: 3.1/10. Value Trap Risk: 39/100 (LOW). 9/13 models active.

Key Facts

Ticker
SONM
Price
$4.34
Quality Score
3.1/10
Value Trap Risk
39/100
Models Active
9/13
Last Updated
Strength: Dynamic NAV suggests +73.2% upside with 45% confidence
Risk: Below-average Quality Score of 3.1/10 signals weak fundamentals

Valuation Matrix

9 Intrinsic Value Models vs. Current Price ($4.34)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
$0.91 -78.9%
CUCE Ensemble
Low Conviction
$3.92 -9.7%
First Chicago
Low Conviction
$2.29 -47.2%
Dynamic NAV
Medium Conviction
$7.52 +73.2%

Unlock the Full Matrix

Access 5 additional models including ML-RIV, PWERM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is DNA X, Inc. (SONM) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, DNA X, Inc.'s intrinsic value is estimated at $3.16, suggesting the stock is overvalued at its current price of $4.34. With 7 out of 9 models flagging downside (-27.1% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: Dynamic NAV targets $7.52 (+73.2%), versus ML-RIV at $0.19 (-95.5%). This +168.7% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About SONM?

9 of 13 models are currently active for SONM. Of these, 2 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates SONM's intrinsic value at $0.91, implying -78.9% downside from the current price. See which stocks rank higher →

How Does SONM Rank in Telephone & Telegraph Apparatus?

Among 9 Telephone & Telegraph Apparatus stocks, SONM ranks #9 by Quality of Company score. CirclFi's QOC score of 3.1/10 evaluates 32 fundamental signals. A score of 3.1 signals below-average fundamentals.

DNA X, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is SONM a Value Trap?

CirclFi's Value Trap algorithm assigns SONM a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for DNA X, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, DNA X, Inc.'s fundamental quality profile registers 3.1/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +168.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SONM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SONM's 9 active models, average confidence is 28%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy DNA X, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Telephone & Telegraph Apparatus Stocks Should You Also Analyze?

8 related Telephone & Telegraph Apparatus stocks with 13-model coverage

Read investment analysis: AUDC · FN · CIEN · NTGR · CLFD

Frequently Asked Questions About DNA X, Inc.

What is DNA X, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, DNA X, Inc. (SONM) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.91. The Quality of Company score is 3.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SONM overvalued or undervalued right now?

At $4.34, 2 of 9 active models suggest SONM may be undervalued, while 7 indicate potential overvaluation. The assessment depends on which methodology best fits DNA X, Inc.'s business model in Telephone & Telegraph Apparatus.

What does a Quality of Company score of 3.1 mean for SONM?

DNA X, Inc.'s QOC of 3.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on SONM?

CirclFi analyzes SONM with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Is SONM a value trap in 2026?

DNA X, Inc.'s Value Trap score is 39/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on SONM.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access